General Society

The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit medical professional society of influential scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Currently, SITC has nearly 1,600 members representing 17 medical specialties and are engaged in research and treatment of at least a dozen types of cancer.

Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance to the field, and commitment to collaborations with like-minded organizations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community in an effort to make cancer immunotherapy one of the four standards of care and the word “cure” a reality for cancer patients living with this disease.

Mission Statement

It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Core Values

Interaction/Integration: Facilitate the exchange of information and education among basic and translational researchers, clinicians, young investigators, societies and groups sharing the mission of SITC

Innovation: Challenge the thinking and seek the best research in the development of cancer immunotherapy

Translation: Facilitate the transfer of cancer immunology and immunotherapy research from the bench to the clinic and back

Leadership: Define what is new and important and effectively communicate it to all relevant stakeholders

Goals

Engage: Strengthen the Society and create a more robust membership base by both attracting new members and retaining the active members through improvement of member benefits and cultivation of key constituency groups

Collaborate: Expand the Society’s impact and influence by establishing relationships with key strategic partners

Learn: Provide education and training about the principles and practice of cancer immunotherapy to be widely recognized as the leading scientific voice in the field